SREBF1 and prostate carcinoma: In line with these results, knockdown of SREBP-1/2 via small interfering RNAs (siRNAs) sensitized prostate cancer cells C4-2 and PC3 to docetaxel-induced cytotoxicity (Fig. S3F).